- Global Pharma News & Resources

Oncolytic Virus Therapy Market Size | Global Industry Research on Growth, Trends and Opportunity 2020-2025

Pune, Maharashtra, India, December 29 2020 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Global Oncolytic Virus Therapy Market valued approximately USD XX million in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Oncolytic Virus Therapy Market is continuously growing across the world over the coming years. The major driving factor of global oncolytic virus therapy market are rising adoption of diagnostic & therapeutics procedure and increase in the number of patients with cancers. The major restraining factor of global oncolytic virus therapy market are lack of awareness among users and new class of anticancer immunotherapy. Oncolytic virus therapy is a virus that preferentially infects and kills cancer cells are destroyed by oncolysis, they extract new infectious viral particles to destroy the remaining tumor. The oncolytic viruses conduct the twice functions as they are not causing only the destruction of cancer infected cells but also stimulate the host anti-tumor immune response & don’t allow the expansion of tumor cells.

Get Sample of This Report@

The regional analysis of Global Oncolytic Virus Therapy Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to well-developed healthcare infrastructure with massive investment in R&D of oncolytic virus immunotherapy. Europe also contributes a satisfactory growth in the global oncolytic Virus therapy market. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 due to increased government initiatives.

The major market player included in this report are:
•    Biovex
•    Cell Genesys
•    Crusade Laboratories
•    Genelux Corporation
•    Lokon Pharma
•    Merck
•    MultiVir

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: 

By Type:
o    Oncolytic Wild Type Viruses
o    Genetically Engineered Oncolytic Viruses

By Application:
o    Breast Cancer
o    Lung Cancer
o    Prostate Cancer
o    Melanoma
o    Brain Tumor
o    Blood Cancer

By Regions:
o    North America
o    U.S.
o    Canada
o    Europe
o    UK
o    Germany
o    Asia Pacific
o    China
o    India
o    Japan
o    Latin America
o    Brazil
o    Mexico
o    Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Oncolytic Virus Therapy Market in Market Study:
o    Key Consulting Companies & Advisors
o    Large, medium-sized, and small enterprises
o    Venture capitalists
o    Value-Added Resellers (VARs)
o    Third-party knowledge providers
o    Investment bankers
o    Investors


Chapter 1.    Executive Summary 
1.1.    Market Snapshot
1.2.    Key Trends
1.3.    Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1.    Oncolytic Virus Therapy Market, by Type, 2015-2025 (USD Billion)
1.3.2.    Oncolytic Virus Therapy Market, by Application, 2015-2025 (USD Billion)
1.3.3.    Oncolytic Virus Therapy Market, by Region, 2015-2025 (USD Billion)
1.4.    Estimation Methodology
1.5.    Research Assumption

Chapter 2.    Oncolytic Virus Therapy Market Definition and Scope 
2.1.    Objective of the Study
2.2.    Market Definition & Scope
2.2.1.    Industry Evolution
2.2.2.    Scope of the Study
2.3.    Years Considered for the Study
2.4.    Currency Conversion Rates

Chapter 3.    Oncolytic Virus Therapy Market Dynamics
3.1.    See Saw Analysis
3.1.1.    Market Drivers
3.1.2.    Market Challenges
3.1.3.    Market Opportunities

Chapter 4.    Oncolytic Virus Therapy Market Industry Analysis

Chapter 5.    Oncolytic Virus Therapy Market, by Type

Chapter 6.    Oncolytic Virus Therapy Market, by Application

Chapter 7.    Oncolytic Virus Therapy Market, by Regional Analysis

Chapter 8.    Competitive Intelligence
8.1.    Company Market Share (Subject to Data Availability)
8.2.    Top Market Strategies
8.3.    Company Profiles
8.3.1.    Biovex    Overview    Financial (Subject to Data Availability)    Product Summary    Recent Developments
8.3.2.    Cell Genesys
8.3.3.    Crusade Laboratories
8.3.4.    Genelux Corporation
8.3.5.    Lokon Pharma
8.3.6.    Merck
8.3.7.    MultiVir


Complete Report Details @

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at





Related Report:

This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 29-Dec-2020